NasdaqGS:HSICHealthcare
Henry Schein (HSIC) Lifts Outlook As Earnings Improve While Valuation Looks Full
Guidance Change and Earnings Put Henry Schein in Focus
Henry Schein (HSIC) raised its 2026 sales growth outlook to a range of 4.5% to 5.5%, alongside second quarter results showing higher sales, net income, and earnings per share compared with the prior year period.
See our latest analysis for Henry Schein.
Henry Schein’s recent guidance increase and earnings report come alongside a 27.08% 3 month share price return and a 33.33% 1 year total shareholder return. This signals building momentum...